Treść książki
Przejdź do opcji czytnikaPrzejdź do nawigacjiPrzejdź do informacjiPrzejdź do stopki
WstępiryshistorycznyXXXV
CollaborativeGroup.Randomisedtrialofintravenousstreptokinase,oral
EńMń,BeasleyJńW.iwsp.:ACC/AHAguidelineupdateforthemanage-
aspirin,both,orneitheramong17,187casesofsuspectedacutemyo-
mentofpatientswithunstableanginaandnonSTelevationmyocardial
cardialinfarction.Lancet,1988;2:349-360.-30.MeyerJń,MerxWń,
infarction:areportoftheAmericanCollegeofCardiology/American
DorrR.iwsp.:Succesfultreatmentofacutemyocardialinfarctionshock
HeartAssociationTaskForceonPracticeGuidelines(Committeeon
bycombinedpercutaneoustransluminalcoronaryrecanalization(PTCR)
theManagementofPatientswithUnstableAngina)2002.www.acc.org.
andpercutaneoustransluminalcoronaryangioplasty(PTCA).Am.Heart
-53.BertrandMńEń,SimoonsMńLń,FoxKńAńiwsp.:Managementofacu-
J.,1982;103:132-134.
tecoronarysyndromes:acutecoronarysyndromeswithoutpersistentST
31.HartzlerGńOń,RutherfordBńDń,McConahayDńRńiwsp.:Percuta-
segmentelevation;recommendationsoftheTaskForceoftheEuropean
neoustransluminalcoronaryangioplastywithandwithoutthrombolytic
SocietyofCardiology.Eur.HeartJ.2000;21:1406-1432.-54.Task
therapyfortreatmentofacutemyocardialinfarction.Am.HeartJ.,1983;
ForceMembres:SilberS.,AlbertssonP.,AvilesF.F.iwsp.:Guidelinesfor
106:965-973.-32.DeBoerMńJ.:Primarycoronaryangioplastyinacute
percutaneouscoronaryinterventions.TheTaskForceforPercutaneo-
myocardialinfarction.Proefschrift,Rotterdam,1994,10-46.-33.Ci-
usCoronaryInterventionsoftheEuropeanSocietyofCardiology.Eur.
garroaRńGń,LangeRńAń,HillisLńDńiwsp.:Prognosisafteracutemyocar-
HeartJ.,2005;26:804-847.-55.ACC/AHAguidelinesforthemanage-
dialinfarctioninpatientswithandwithoutresidualanterogradecoronary
mentofpatientswithST-elevationmyocardialinfarction.2004;available
bloodflow.Am.J.Cardiol.,1989;64:155-160.-34.BraunwaldE.:My-
AT:www.acc.org.www.americanheart.org.-56.GrupaRoboczaSekcji
ocardialreperfusion,limitationofinfarctsize,reductionofleftventricu-
KardiologiiInterwencyjnej.Zaleceniapostępowaniawkardiologiiinwa-
lardysfunction,andimprovedsurvival:shouldtheparadigmbeexpan-
zyjnej(red.R.J.Gil,A.Witkowski,L.Poloński).W:KardiologiaPolska
ded?Circulation,1989;79:441-444.-35.SolomonSńDń,RidkerPńMń,
2005,63(supl.3).-57.MńDąbrowski:Zaleceniadotycząceimplantacji
AntmanEńMń:Ventriculararrhythmiasintrialsofthrombolytictherapy
stentówdotętnicszyjnych.Kard.Pol.,2007;65:93-98(supl.1).-58.
foracutemyocardialinfarction.Ameta-analysis.Circulation,1993;
BiałkowskiJń,SzkutnikMń,ZembalaM.:Rolakardiochirurgiiikardio-
2575-2581.-36.KahnJńKń,RutherfordBńDń,McConahayDńRńiwsp.:
logiiinterwencyjnejwzamykaniuubytkówkomorowych.Kardiol.Pol.,
Catheterizationlaboratoryeventsandhospitaloutcomewithdirectangio-
2007;65:1022-1024.-59.LockJńEń,BlockPńCń,McKayRńGńiwsp.:
plastyforacutemyocardialinfarction.Circulation,1990;82:1910-1915.
Transcatheterclosureofventricularseptaldefects.Circulation,1988;78:
-37.CaliffRńMń,TopolEńJń,StackRńS.iwsp.:Evaluationofcombination
361-368.-60.HijaziZńMń,HahimFń,HuwelahAńA.iwsp.:Catheterclo-
thrombolytictherapyandtimingofcardiaccatheterizationinacutemyo-
sureofperimembranousventricularseptaldefectsusingthenewAmplat-
cardialinfarction.Resultsofthrombolysisandangioplastyinmyocardial
zermembranousVSDoccluder:initalclinicalexperience.Cardiovasc.
infarction-phase5randomizedtrial.Circulation,1991;83:1543-1556.
Interv.,2002,56:508-515.
-38.EllisSńGń,DeBoweyDń,BatesEńR.iwsp.:Treatmentofrecurrent
61.LeeEńMń,RobertsDńHń,WelshKńiwsp.:Transcatheterclosureof
ischemiaafterthrombolysisandsuccessfulreperfusionforacutemyocar-
theresidualpostmyocardialinfarctionventricularseptaldefectRusing
dialinfarction:effectonin-hospitalmortalityandleftventricularfun-
Amplatzeratrialseptaloccluder.Heart,1998;80:522-524.-62.Dem-
ction.J.Am.Coll.Cardiol.,1991;17:751-757.-39.O’NeillWńWń,Wein-
kowMń,RużyłłoWń,KępkaCńiwsp.:Primarytranscatheterclosureof
traubRń,GrinesCńLńiwsp.:Aprospective,placebo-controlled,randomi-
postinfarctionventricularseptaldefectswiththeAmplatzerseptal.Occlu-
zedtrialofintravenousstreptokinaseandangioplastyversusloneangio-
der-immediateresultsandup-to5-yearsfollow-up.Eurointervention,
plastytherapyofacutemyocardialinfarction.Circulation,1992;86:
2005;1:43-47.-63.SzkutnikMń,KursaJń,BiałkowskiJ.:Pozawałowe
1710-1717.-40.AbbottsmithCńWń,TopolEńJń,GeorgeBńSńiwsp.:Fate
ubytkiprzegrodymiędzykomorowej.CzęśćII.Wynikiprzezcewnikowe-
ofpatientswithacutemyocardialinfarctionwithpatencyoftheinfarct-
gozamykaniaubytków.Pol.Przeg.Kardiol.,2008;10;109-114.-64.
-relatedvesselachievedwithsuccessfulthrombolysisversusrescuean-
InoueKń,OwakiTń,NakamuraTńiwsp.:Clinicalapplicationoftransve-
gioplasty.J.Am.Coll.,Cardiol.,1990;16:770-778.
nousmitralcommissurotomybyanewballooncatheter.J.Thorac.Car-
41.EllisSńGń,RiberiodaSilvaEń,HeyndrickxGńR.iwsp.:Finalresults
diovasc.Surgery,1984;87(3):394-402.-65.DąbrowskiM.:Zabiegi
oftherandomizedRESCUEstudyevaluatingPTCAafterfailedthrombo-
przezskórneudorosłychzzastawkowąwadąserca.KardiologiapoDy-
lysisforpatientswithanteriorinfarction.Circulation,1993;88:I-106
plomie,2007;3:26-32.-66.FeldmanTń,WassermanHńSń,Herrmann
(abstr.).-42.EckamanMńHń,WongJńBń,SalemDńN.iwsp.:Directangio-
HńC.iwsp.:Percutaneousmitralvalverepairusingtheedge-to-edgetech-
plastyforacutemyocardialinfarction.Ann.Intern.Med.,1992;117:
niquesix-monthresultsoftheEVERESTPhaseinClinicalTrial.J.Am.
667-676.-43.O’NeillWńWń,TimmisGńCń,BourdillonPńD.iwsp.:Apro-
C.Cardiol.,2005;46:2134-2140.-67.WebbJńGń,HarnekJń,MuntBńI.
spectiverandomizedtrialofintracoronarystreptokinaseversuscoronary
iwsp.:Percutaneoustransvenousmitralannuloplasty:initialhumanexpe-
angioplastyforacutemyocardialinfarction.N.Engl.J.Med.,1986;314:
riencewithdeviceimplantationinthecoronarysinus.Circulation,2006;
812-818.-44.ZijlstraFń,deBoerMńJń,HoorntjeJńCńA.iwsp.:Acom-
113:851-855.-68.BonhoefferPń,BondjemlineYń,SolibaZ.iwsp.:Per-
parisonofimmediatecoronaryangioplastywithintravenousstreptokina-
cutaneousreplacementofpulmonaryvalveinright-ventricletopulmo-
seinacutemyocardialinfarction.N.Engl.J.Med.,1993:328:680-684.
nary-arteryprostetickonduitwithvalvedysfunction.Lancet,2000,21;
-45.GrinesCńLń,BrowneKńFń,MarcoJ.iwsp.:Acomparisonofimme-
356:1403-1405.-69.BonhoefferPń,BondjemlineYń,QuereskiSńAń
diateangioplastywiththrombolytictherapyforacutemyocardialin-
iwsp.:Percutaneousinsertionofpulmonaryvalve.J.Am.Coll.Card.,
farction.N.Engl.J.Med.,1993;328:673-679.-46.GibbonsRńJń,Hol-
2002,15;39:1664-1669.-70.JungBń,CachierAń,BaronGńiwsp.:
mesDńRń,ReederGńSńiwsp.:Immediateangioplastycomparedwiththe
Decision-makinginelderlypatientswithsevereaorticstenosis:whyare
administrationofathrombolyticagentfollowedbyconservativetreat-
somanydeniedsurgery?Eur.HeartJ.,2005;26:2714.
mentformyocardialinfarction.N.Engl.J.Med.,1993;328:685-691.-
71.CribierAń,EltchaminoffHń,BaschA.iwsp.:Percutaneoustransca-
47.O’KeefeJńHń,BaileyWńLń,RutherfordBńD.iwsp.:Primaryangiopla-
theterimplantationofanaorticvalveprosthesisforcalcificaorticsteno-
styforacutemyocardialinfarctionin1000consecutivepatients.Results
sis:firsthumancasedescription.Circulation,2002,10,106(24):3006-
inanunselectedpopulationandhigh-risksubgroups.Am.J.Cardiol.,
-3008.-72.VehanianAń,AlfieriOńRń,Alń-AttarNńiwsp.:Transcatheter
1993;72:107G-115G.-48.ZahnRń,SchieleRń,SchneiderS.iwsp.:
valveimplantationforpatientswithaorticstenosis:apositionstatement
Decreasinghospitalmortalitybetween1994and1998inpatientswith
fromEuropeanAssociationofCardio-ThoracicSurgery(EACTS)and
acutemyocardialinfarctiontreatedwithprimaryangioplastybutnotin
EuropeanSocietyofCardiology(ESC)incollaborationwiththeEurope-
patientstreatedwithintravenousthrombolysis.Resultsfromthepooled
anAssociationofPercutaneousCardiovascularInterventions(EAPCI).
dataofthemaximalindividualtherapyinacutemyocardialinfarction
Eur.HeartJ.2008,11:1463-1470.Eur.J.Cardiothorac.Surg.,2008;
(MITRA)registryandthemyocardialinfarctionregistry(MIR).J.Am.
34(1):1-8.-73.RużyłłoWń,KańtochMń,DąbrowskiMń:Przezskórna
Call.Cardiol.,2000,36;2064-2071.-49.MagidDńJń,CalongeBńNń,
angioplastykawkoarktacjiaorty.Kardiol.Pol.,1988;31:7.-74.Magee
RumsfeldJńSńiwsp.:Relationbetweenhospitalprimaryangioplastyvo-
AńGń,Brzezińska-RajszysGń,QuershiSńA.iwsp.:Endovascularstentsfor
lumeandmortalityforpatientswithacuteMItreatedwithprimaryangio-
coarctationoftheaorta:Initialresultsandintermediate-termfollow-up.
plastyvsthrombolytictherapy.JAMA,2000;284:3131-3138.-50.Wi-
JournalofInterventionalCardiology,2003;166:413.-75.NihillMńRń,
dimskyPń,GrochLń,ZelizkoMńiwsp.:Multicentrerandomizedtrialcom-
O’LaughlinMńPń,MullinsCńEń:Effectsofatrialseptostomyinpatients
paringtransporttoprimaryangioplastyvsimmediatethrombolysisvs
withterminalcorpulmonaleduetopulmonaryvasculardisease.Cathet.
combinedstrategyforpatientswithacutemyocardialinfarctionpresen-
Cardiovasc.Diagn.,1991;24:166-172.-76.SandovalJń,GasparJń,
tingtoacommunityhospitalwithoutacatheterizationlaboratory.The
PulidoTńiwsp.:Gradedballoondilationatrialseptostomyinseverepri-
PRAGUEstudy.Eur.Heart.J.2000;21:823-831.
marypulmonaryhypertension.Atherapeuticalternativeforpatientsnon-
51.HenningRńAńiwsp.:TheDanishmulticenterrandomizedtrialon
responsivetovasodilatortreatment.J.Am.Coll.Cardiol.,1998;32:
thrombolytictherapyvsacutecoronaryangioplastyinacutemyocardial
297-304.-77.RużyłłoW.:Arteriografiawieńcowa.Pol.Przegl.Rad.
infarction-Danami-2.www.danami-2.dk.-52.BraunwaldEń,Antman
iMed.Nukl.,1969;33:597.-78.RużyłłoW.:Koronarografiaselektywna
